It was revealed that the anti-cancer activity of SFN is modulated by a variety of cell-signaling pathways including NF-κB signaling (12), Keap1– Nrf2 signaling (13), and ROS-dependent pathway (14). This evidence concerns the gene NFKB1 and cancer.